He was one of Singapore’s first medical oncologists and now in his late seventies, Dr Tan Yew Oo is one of the oldest practising oncologists, seeing cancer patients daily and striving to make a difference.
+65 3158 9940
1300 798 820
+64 9801 0299
He was one of Singapore’s first medical oncologists and now in his late seventies, Dr Tan Yew Oo is one of the oldest practising oncologists, seeing cancer patients daily and striving to make a difference.
At homegrown pharma company Specialised Therapeutics, 82 per cent of employees are women, three in every four employees is aged over 40, and nine of the 12 executive team members is female.
Age, gender, and ethnicity are not a consideration when hiring, says CEO Carlo Montagner, who instead employs people that best fit with the values of the business he co-founded with his wife, Bozena Zembrzuski.
PHARMA IN FOCUS By Christine Spiteri 10 February 2022 Who’s Mandated a Third Jab? Specialised Therapeutics has made a third COVID-19 vaccine compulsory for all staff, to ensure a safe office environment for employees returning to work. The team was told on Christmas Eve last year that booster shots for those who were eligible would
Rare Cancers Australia CEO Richard Vines discusses affordable access to specialist medicines. Click for more.
As a young boy, Andrew Dean was fascinated with aeroplanes. But the son of Liverpool publicans quickly realised that flying lessons were a lofty pursuit his family probably could not afford. It was many years later, after training first as a palliative care and internal medicine physician that the medical oncologist decided his sky-high ambition was finally within reach.
ST is delighted to announce that our therapy QINLOCK® (ripretinib) was reimbursed for eligible Australian GIST patients from December 1 2021. International GIST expert Professor John Zalcberg reacts to the listing. Click for more.
PHARMA IN FOCUS By Christine Spiteri 21 December 2021 Job Boom Hits Growing Pharma Specialised Therapeutics is experiencing a mini-jobs boom, with the company’s growing portfolio and expansion across South East Asia requiring a boost to its workforce. The company currently has a staff of about 40 but is actively looking to fill five new
Melbourne mother of two Renee Van Beelan was diagnosed with GIST (Gastrointestinal Stromal Tumours) almost five years ago. Her baby daughter was just eight weeks old and the devastated new mother did not know what the future held. New therapies provide hope for the future. Click on the video above to hear Renee speak about
Rare Cancers Australia CEO Richard Vines says Australian GIST patients were determined to help achieve a PBS listing for a new therapy to treat the disease and their persistence has paid off with QINLOCK® (ripretinib) now reimbursed. Click for more.
What is GIST? We are passionate about making a difference for patients living with rare cancers. Here, Professor John Zalcberg provides an overview of Gastrointestinal Stromal Tumours. Click for more.